by Plus Therapeutics | Nov 21, 2024 | LM
Plus Therapeutics to Present Groundbreaking Data on CNSide™ Cerebrospinal Fluid Assay at SNO Annual Meeting in Houston Plus Therapeutics is excited to present new findings at the Society for Neuro-Oncology (SNO) Annual Meeting in Houston, focusing on our CNSide™...
by Plus Therapeutics | Nov 19, 2024 | LM
Early Detection Saves Lives: Lung Cancer and Leptomeningeal Metastases Awareness Did you know that early detection of metastatic lung cancer can improve survival rates? This Lung Cancer Awareness Month, let’s take the opportunity to educate ourselves about the...
by Plus Therapeutics | Nov 18, 2024 | LM
Join Plus Therapeutics at the SNO Annual Meeting in Houston! Are you attending the 2025 Society for Neuro-Oncology (SNO) Annual Meeting in Houston this week? So are we! Plus Therapeutics is excited to showcase our latest research, symposium, oral presentations, and...
by Plus Therapeutics | Nov 15, 2024 | GBM
Plus Therapeutics at the ABTA Race in New York: Supporting Brain Cancer Awareness and Education Check out this photo of our dedicated patient advocacy team at the @the_ABTA race in New York last weekend! The Plus Therapeutics team was proud to support and participate...
by Plus Therapeutics | Nov 15, 2024 | Uncategorized
ICYMI: Watch the Plus Therapeutics Q3 2024 Conference Call Webcast Replay Catch up on the latest financial results and updates from Plus Therapeutics! If you missed yesterday’s conference call, don’t worry – you can still access the webcast replay to hear...
Recent Comments